VISION
We envision a world that cancer is no longer a devastating disease, because of collective efforts including ours to develop better medicines.
MISSION
To discover, develop, and diver transformative xenogeneic cellular medicines to cancer patients and improve their outcomes. eXCELL is a company dedicated to developing revolutionary therapies to meliorate people’s lives.
Xenogeneic cell immunotherapy
eXCELL is an immunotherapy company that uses the body built-in immune rejection responses to non-self cells to combat the difficult-to-treat cancers by utilizing xenogeneic cells that could promote cancer immunity cycle due to the similarities between xenogeneic cells and tumor cells.